NCT Number: NCT02691481
Diabetes-Specific Nutritional Formulas Versus Oatmeal
Diabetes-specific nutritional formulas (DSNFs) are frequently used as part of medical nutrition therapy for patients with type 2 diabetes in order to improve glycemic control and enhance weight reduction. The mechanism through which DSNFs improve postprandial (PP) plasma glucose is not yet known.
The aim of this study is to compare the effects of 2 DSNFs versus oatmeal on PP plasma glucose, serum insulin and serum active glucagon-like peptide-1 (GLP-1), serum free fatty acids (FFA) and serum triglycerides (TG).
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with type 2 diabetes treated with oral diabetes medications
Exclusion criteria
- Type 1 diabetes
Treatment and study plan
Glucerna formula
Dietary SupplementUltra Glucose Control formula
Dietary SupplementPrimary outcomes
-
Glucose area under the curve 0-240 minutes
Time frame: 240 minutes
Sponsors and collaborators
Lead sponsor
Joslin Diabetes Center
Other
Registry information
Official study title
Effect of Diabetes-specific Formulas on Glucose Metabolism and GLP-1 Secretion in Patients With Type 2 Diabetes
Important dates
- Study start
- 2014
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Feb 25, 2016
- Registry last updated
- Feb 25, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Injectable Semaglutide vs Dulaglutide in Individuals at Cardiovascular Risk
NCT07619495
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsAlliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes
NCT02328599
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsA Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
NCT05110846
Body Weight, Diabetes Mellitus
Guadalajara, Jalisco, Mexico
View Trial DetailsA Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
NCT05394519
Body Weight, Diabetes Mellitus
Concord, California, United States
View Trial Details